INKON Life Technology Co., Ltd. (SHE:300143)

Market Cap	9.89B +29.3%
Revenue (ttm)	1.89B +20.9%
Net Income	68.54M -40.6%
EPS	0.09 -50.0%
Shares Out	743.29M
PE Ratio	147.78
Forward PE	63.33
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,025,510
Average Volume	33,496,349
Open	12.78
Previous Close	12.62
Day's Range	12.68 - 13.34
52-Week Range	8.12 - 14.38
Beta	0.88
RSI	60.46
Earnings Date	Mar 28, 2026

About INKON Life Technology

INKON Life Technology Co., Ltd. focuses on building an ecological platform for chain of prevention / diagnosis / treatment / rehabilitation, providing medical services for tumors in China and internationally. It provides medical devices solution for radiotherapy, life support, image enhancement, and chronic disease treatment, as well as oncology medical services. The company was formerly known as Starmap Medicine and Technology Co., Ltd. and changed its name to INKON Life Technology Co., Ltd. in July 2019. INKON Life Technology Co., Ltd. was fo...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 2,207
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300143

Financial Performance

In 2025, INKON Life Technology's revenue was 1.89 billion, an increase of 20.93% compared to the previous year's 1.56 billion. Earnings were 68.54 million, a decrease of -40.62%.